The role of Fas-associated death domain in necroptosis in vivo
Fas相关死亡结构域在体内坏死性凋亡中的作用
基本信息
- 批准号:8295838
- 负责人:
- 金额:$ 37.68万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-03-02 至 2017-02-28
- 项目状态:已结题
- 来源:
- 关键词:AddressAffinity ChromatographyAntibioticsAntigensApoptosisApoptoticAutoimmunityBacteriaBinding ProteinsBiochemicalCaspaseCell AgingCell DeathCell Death Signaling ProcessCellsCessation of lifeCo-ImmunoprecipitationsComplexDataDeath DomainDendritic CellsErythrocytesExhibitsFas Signaling PathwayHumanImmuneImmune responseImmune systemImmunityInfectionInflammationInflammatoryInfluenzaInjection of therapeutic agentInterphase CellKnock-outKnockout MiceLeadLigandsLipopolysaccharidesMass Spectrum AnalysisMediatingModelingMusMutant Strains MiceMyeloproliferative diseaseNecrosisParasitesPathway interactionsPhenotypePhosphotransferasesPhysiologicalPlayPredispositionProliferatingProteinsRIPK3 geneResistanceRoleRunningSalmonella infectionsSerumShapesSignal PathwaySignal TransductionStimulusSyndromeT-Cell ProliferationT-Cell ReceptorT-LymphocyteTLR4 geneTestingTimeTissuesToll-like receptorsToxoplasma gondiiToxoplasmosisTransfectionTransgenic MiceTumor Necrosis Factor ReceptorTumor Necrosis Factor-alphaVaccinesViralWestern Blottingadapter proteinagedcaspase-8cell agecell typecytokineimprovedin vivomacrophagemembermouse developmentmouse modelneutrophilpathogenprematureprogramsreceptorresponseubiquitin-protein ligase
项目摘要
DESCRIPTION (provided by applicant): Cell death is an integral part of the immune responses to pathogenic infection, and different forms of cell death can have different immunological consequences. For example, apoptosis is thought to clear viral infected cells and to control run-away immune responses whereas pyroptosis of macrophages can result in the release of cytokines. The Tumor Necrosis Factor Receptor (TNF-R) family of death receptors can trigger apoptosis but also an alternative form of death called programmed necrosis or necroptosis. Necroptosis is dependent on the RIP1 and RIP3 kinases but little is known on its physiological role. To address this, we have generated three lines of tissue- specific FADD knockout mice. FADD is a known adapter protein for all the TNF-R death receptors and thus FADD-deficient cells are resistant to death receptor-mediated apoptosis. However, stimulation of FADD-deficient cells leads to death through necroptosis. This occurs in T-cell receptor stimulated T cells from T-cell specific-FADD knockout (tFADD-/-) mice, in lipopolysaccharide (LPS) stimulated dendritic cells (DCs) from DC-specific-FADD deficient (dcFADD-/-) mice and in LPS stimulated macrophages from macrophage-specific FADD deficient (mFADD-/-) mice. T cells from tFADD-/- mice are functionally defective due to premature necroptosis. However, FADD-deficient DCs are functionally normal and can secrete cytokines when stimulated. Analysis of dcFADD-/- mice showed that some of their phenotypes are surprisingly similar to DC-less mice with imbalance erythrocytes and myeloproliferative disease. At the same time, dcFADD-/- mice exhibit a modest increase of inflammation. In contrast to other DC-specific apoptosis-resistant mice, aged dcFADD-/- mice don't suffer from autoimmunity but they appear to have an enhanced immune system. We hypothesize that necroptosis is one of the strategies for innate immune cells to stimulate the immune system in cases when receptor-induced apoptosis is blocked. In dcFADD-/- mice, necroptotic DCs releasing inflammatory contents can lead to improved immunity against pathogenic infection. This hypothesis will be tested in aim 1. Using DC-specific FADD-/-/MyD88-/- and dcFADD-/-/RIP3-/- mice, we will address whether constitutive stimulation of DCs through TLRs leads to necroptosis and release of inflammatory contents. To examine the possible enhanced immunity of dcFADD-/- mice, they will be challenged with influenza and Toxoplasma gondii and studied in details. Whether necroptosis is required for immunity against these two pathogens will be assessed using RIP3-/- mice. In Aim 2, we will unravel the biochemical signaling pathways involving FADD in necroptosis in response to TLR stimulation. Successful completion of these aims will greatly enhance our understanding of the host- pathogen interaction and the physiological role of necroptosis. ! ! !
PUBLIC HEALTH RELEVANCE: Cell death, including apoptosis, pyroptosis, autophagic cell death and necrosis, is an integral part of development of the mouse/human immune system and/or responses to pathogenic infection. Members of the tumor necrosis factor (TNF) death receptors can initiate apoptosis and a new form of necrosis called necroptosis but the physiological role of necroptosis is poorly understood; we propose in this application to understand the role of necroptosis in infection by studying mouse models deficient in an adapter protein required for the TNF cell death signals.
描述(由申请人提供):细胞死亡是对病原体感染的免疫反应的一个组成部分,不同形式的细胞死亡可能会有不同的免疫学后果。例如,细胞凋亡被认为可以清除受病毒感染的细胞,控制失控的免疫反应,而巨噬细胞的松弛可以导致细胞因子的释放。肿瘤坏死因子受体(TNF-R)家族的死亡受体可以触发细胞凋亡,但也可以引发另一种形式的死亡,称为程序性坏死或坏死性下垂。坏死性上睑下垂依赖于RIP1和RIP3激酶,但对其生理作用知之甚少。为了解决这个问题,我们培育了三种组织特异性FADD基因敲除小鼠。FADD是已知的所有肿瘤坏死因子受体死亡受体的适配蛋白,因此FADD缺陷细胞对死亡受体介导的细胞凋亡具有抵抗力。然而,对FADD缺陷细胞的刺激会导致坏死性下垂死亡。这发生在T细胞特异性FADD基因敲除(tFADD-/-)小鼠的T细胞受体刺激的T细胞、DC特异性FADD缺陷(dcFADD-/-)小鼠的内毒素刺激的树突状细胞(DC)和巨噬细胞特异性FADD缺陷小鼠(mFADD-/-)的内毒素刺激的巨噬细胞中。来自tFADD-/-小鼠的T细胞由于过早的坏死性下垂而出现功能缺陷。然而,FADD缺陷的DC在功能上是正常的,在受到刺激时可以分泌细胞因子。对dcFADD-/-小鼠的分析表明,他们的一些表型与缺乏DC的红细胞失衡和骨髓增生性疾病的小鼠惊人地相似。与此同时,dcFADD-/-小鼠的炎症反应略有增加。与其他DC特异性抗凋亡小鼠不同,老年dcFADD-/-小鼠不会受到自身免疫的影响,但它们的免疫系统似乎得到了增强。我们假设,当受体诱导的细胞凋亡被阻断时,坏死性下垂是先天免疫细胞刺激免疫系统的策略之一。在dcFADD-/-小鼠中,坏死性DC释放炎症内容物可提高对病原性感染的免疫力。这一假设将在目标1中得到验证。使用DC特异性的FADD-/-/MyD88-/-和dcFADD-/-/RIP3-/-小鼠,我们将研究通过TLRs对DC的结构性刺激是否会导致坏死性下垂和炎性物质的释放。为了检测dcFADD-/-小鼠可能的增强免疫力,将用流感和弓形虫攻击它们,并进行详细的研究。对这两种病原体的免疫是否需要坏死性下垂将使用RIP3-/-小鼠进行评估。在目标2中,我们将揭开FADD参与坏死性下垂对TLR刺激的反应的生化信号通路。这些目标的成功完成将极大地提高我们对宿主-病原体相互作用和坏死性下垂的生理作用的了解。!!!
公共卫生相关性:细胞死亡,包括细胞凋亡、下垂、自噬细胞死亡和坏死,是鼠/人免疫系统发育和/或对病原体感染反应的一个组成部分。肿瘤坏死因子死亡受体的成员可以启动细胞凋亡和一种称为坏死性下垂的新形式的坏死,但对坏死性下垂的生理作用知之甚少;在这一应用中,我们建议通过研究缺乏肿瘤坏死因子细胞死亡信号所需的适配蛋白的小鼠模型来了解坏死性下垂在感染中的作用。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ASTAR WINOTO其他文献
ASTAR WINOTO的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ASTAR WINOTO', 18)}}的其他基金
The role of Fas-associated death domain in necroptosis in vivo
Fas相关死亡结构域在体内坏死性凋亡中的作用
- 批准号:
8997965 - 财政年份:2012
- 资助金额:
$ 37.68万 - 项目类别:
The role of Fas-associated death domain in necroptosis in vivo
Fas相关死亡结构域在体内坏死性凋亡中的作用
- 批准号:
8436162 - 财政年份:2012
- 资助金额:
$ 37.68万 - 项目类别:
The role of Fas-associated death domain in necroptosis in vivo
Fas相关死亡结构域在体内坏死性凋亡中的作用
- 批准号:
8609544 - 财政年份:2012
- 资助金额:
$ 37.68万 - 项目类别:
Role of " Apoptotic proteins" Regulation Innate Immunity
“凋亡蛋白”调节先天免疫的作用
- 批准号:
7081706 - 财政年份:2006
- 资助金额:
$ 37.68万 - 项目类别:
TRAIL receptor in apoptosis and the immune system
TRAIL受体在细胞凋亡和免疫系统中的作用
- 批准号:
6603117 - 财政年份:2001
- 资助金额:
$ 37.68万 - 项目类别:
TRAIL receptor in apoptosis and the immune system
TRAIL受体在细胞凋亡和免疫系统中的作用
- 批准号:
6927959 - 财政年份:2001
- 资助金额:
$ 37.68万 - 项目类别:
TRAIL receptor in apoptosis and the immune system
TRAIL受体在细胞凋亡和免疫系统中的作用
- 批准号:
6359738 - 财政年份:2001
- 资助金额:
$ 37.68万 - 项目类别:
TRAIL receptor in apoptosis and the immune system
TRAIL受体在细胞凋亡和免疫系统中的作用
- 批准号:
6755891 - 财政年份:2001
- 资助金额:
$ 37.68万 - 项目类别:
TRAIL receptor in apoptosis and the immune system
TRAIL受体在细胞凋亡和免疫系统中的作用
- 批准号:
6515156 - 财政年份:2001
- 资助金额:
$ 37.68万 - 项目类别:
相似海外基金
Cellular membrane affinity chromatography kit for drug discovery
用于药物发现的细胞膜亲和层析试剂盒
- 批准号:
10506915 - 财政年份:2021
- 资助金额:
$ 37.68万 - 项目类别:
Cellular membrane affinity chromatography kit for drug discovery
用于药物发现的细胞膜亲和层析试剂盒
- 批准号:
10325006 - 财政年份:2021
- 资助金额:
$ 37.68万 - 项目类别:
SBIR Phase I: A New Class of Immobilized Metal Affinity Chromatography Resins
SBIR 第一阶段:一类新型固定金属亲和色谱树脂
- 批准号:
1746198 - 财政年份:2018
- 资助金额:
$ 37.68万 - 项目类别:
Standard Grant
Marine speciation of nickel using immobilized nickel affinity chromatography
使用固定镍亲和色谱法测定镍的海洋形态
- 批准号:
512537-2017 - 财政年份:2017
- 资助金额:
$ 37.68万 - 项目类别:
University Undergraduate Student Research Awards
I-Corps: Commercialization of Immobilized Metal Affinity Chromatography Resins Based on Nanomaterials
I-Corps:基于纳米材料的固定化金属亲和层析树脂的商业化
- 批准号:
1404605 - 财政年份:2014
- 资助金额:
$ 37.68万 - 项目类别:
Standard Grant
Antibody Purification via Affinity Chromatography that Utilizes the Unconventional Nucleotide Binding Site
利用非常规核苷酸结合位点通过亲和色谱法纯化抗体
- 批准号:
1263713 - 财政年份:2013
- 资助金额:
$ 37.68万 - 项目类别:
Continuing Grant
Development of multivalent DNA network based affinity chromatography diagnostics for isolating circulating tumour cells
开发基于多价 DNA 网络的亲和色谱诊断法,用于分离循环肿瘤细胞
- 批准号:
425749-2012 - 财政年份:2012
- 资助金额:
$ 37.68万 - 项目类别:
Postgraduate Scholarships - Master's
Next-Generation Affinity Chromatography with PEGylated Ligands
使用聚乙二醇化配体的新一代亲和色谱法
- 批准号:
1159886 - 财政年份:2012
- 资助金额:
$ 37.68万 - 项目类别:
Standard Grant
Immobilized zirconium ion affinity chromatography for specific enrichment of phosphoproteins
用于磷蛋白特异性富集的固定化锆离子亲和层析
- 批准号:
19560760 - 财政年份:2007
- 资助金额:
$ 37.68万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Accelerating drug discovery using frontal affinity chromatography/mass spectrometry
使用正面亲和色谱/质谱加速药物发现
- 批准号:
234753-2000 - 财政年份:2003
- 资助金额:
$ 37.68万 - 项目类别:
Collaborative Research and Development Grants